)
Integra LifeSciences (IART) investor relations material
Integra LifeSciences 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Market Positioning and Business Overview
Holds leading positions in neurosurgery and tissue technologies, with $1.6B in annual revenue and strong margins.
Demonstrates leadership in a $9.1B global medtech market, serving specialized, high-value markets with essential products.
Strong brand equity, commercial excellence, and expertise in tissue reconstruction and neurosurgery.
Positioned to capitalize on demographic trends, technology adoption, and international expansion.
Products address critical needs in brain surgery, trauma, burns, and hernia repair.
Strategic Transformation and Operational Focus
Undergoing a significant, multi-year transformation to improve operational performance and consistency.
Executing a two-horizon strategy: first, building a sustainable foundation; second, accelerating growth.
Four strategic imperatives: best-in-class quality, supply chain reliability, growth acceleration, and innovation.
Investments in supply chain resiliency and capacity expansion to support global demand.
Portfolio prioritization guides capital allocation to high-growth, high-margin areas.
Financial Performance and Outlook
Reported trailing 12-month revenue of $1.6B, with a 62.8% adjusted gross margin and 19% adjusted EBITDA margin.
Margin expansion plan launched, targeting $25M–$30M in savings for 2026.
Operating cash flow reached $89M for the same period.
Guidance for 2026 expects modest revenue and earnings growth, with supply reliability and product relaunches as key drivers.
Leverage ratio at 4.3x in Q3, with a goal to approach 2.5–3.5x by end of 2026.
- TimeTickerHeadlineOpen
- 7 FebSBIN
Q3 FY26 net profit hit INR 21,028 crore, driven by growth, divestments, and digital gains. - 7 FebGICRE
Net profit for the nine months surged to ₹6,62,217 lakhs, with a robust solvency ratio of 3.87. - 7 Feb517271
Strong revenue and profit growth, interim dividend, and major investments approved. - 7 Feb514167
Quarterly and nine-month results reflect solid revenue, profit, and compliance with new labour codes. - 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus.
Next Integra LifeSciences earnings date
Next Integra LifeSciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)